Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Total 13F shares
-
28,820,386
-
Share change
-
+935,154
-
Total reported value
-
$1,337,495,830
-
Put/Call ratio
-
3659%
-
Price per share
-
$46.29
-
Number of holders
-
169
-
Value change
-
+$25,681,228
-
Number of buys
-
69
-
Number of sells
-
118
Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q4 2015
As of 31 Dec 2015,
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) was held by
169 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,820,386 shares.
The largest 10 holders included
Fisher Asset Management, LLC, AQR CAPITAL MANAGEMENT LLC, COMMONWEALTH BANK OF AUSTRALIA, VANGUARD GROUP INC, VONTOBEL ASSET MANAGEMENT INC, BlackRock Group LTD, DIMENSIONAL FUND ADVISORS LP, ROYAL BANK OF CANADA, CREDIT SUISSE AG/, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
169
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.